Current position:Home >Product >
[hydroxy-[(3E,7E,11E,15E,19E,23E,27E,31E)-4,8,12,16,20,24,28,32,36-nonamethylheptatriaconta-3,7,11,15,19,23,27,31,35-nonaenoxy]phosphoryl]oxyphosphonic acid
[hydroxy-[(3E,7E,11E,15E,19E,23E,27E,31E)-4,8,12,16,20,24,28,32,36-nonamethylheptatriaconta-3,7,11,15,19,23,27,31,35-nonaenoxy]phosphoryl]oxyphosphonic acid(146340-00-3)
- Name: [hydroxy-[(3E,7E,11E,15E,19E,23E,27E,31E)-4,8,12,16,20,24,28,32,36-nonamethylheptatriaconta-3,7,11,15,19,23,27,31,35-nonaenoxy]phosphoryl]oxyphosphonic acid
- Synonyms:Diphosphoricacid,mono(3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl)ester, (Z,Z,Z,Z,Z,Z,E,E)-; Diphosphoric acid,mono[(2Z,6Z,10Z,14Z,18Z,22Z,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethyl-2,6,10,14,18,22,26,30,34-hexatriacontanonaenyl]ester (9CI); Solanesyl pyrophosphate; Solanesyl-PP
- Molecular Formula:C45H76 O7 P2
- Molecular Weight:791.03
- CAS Registry Number:146340-00-3
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.146340-00-3 [hydroxy-[(3E,7E,11E,15E,19E,23E,27E,31E)-4,8,12,16,20,24,28,32,36-nonamethylheptatriaconta-3,7,11,15,19,23,27,31,35-nonaenoxy]phosphoryl]oxyphosphonic acid
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 146293-91-6/3-Isoxazoleaceticacid,-alpha--ethylidene-,(Z)-(9CI)
- 146294-17-9/Quinoxaline, 6-methoxy-2-methyl-
- 146294-18-0/Quinoxaline, 7-methoxy-2-methyl-
- 146295-00-3/Glycine, N-(3-hydroxy-2-pyridinyl)- (9CI)
- 146307-61-1/2H-Pyran-2-methanol,tetrahydro-2-methyl-6-(1-methylethyl)-,cis-(9CI)
- 146307-62-2/2H-Pyran-2-methanol,tetrahydro-2-methyl-6-(1-methylethyl)-,trans-(9CI)
- 146309-01-5/8-Azabicyclo[3.2.1]oct-6-ene,8-methyl-(9CI)
- 146324-43-8/(S)-2-FLUOROBENZHYDROL
- 146351-00-0/Benzoic acid, 3,4-diamino-2-butyl- (9CI)
- 146351-93-1/2-AMINO-3,5-DIMETHYL-BENZONITRILE
- 146353-52-8/3-Pyridinecarbonitrile, 2-amino-4-cyclopropyl-
- 146329-67-1/2-Octanone, 3-hydroxy-, (3R)- (9CI)
- 146331-19-3/2-Amino-6,7-dihydro-5H-1-pyrindine
- 146335-11-7/Ethanone, 2-fluoro-1-[2-[(methoxymethyl)thio]phenyl]- (9CI)
- 146335-13-9/Ethanone, 2-fluoro-1-[4-[(methoxymethyl)thio]phenyl]- (9CI)
- 146335-23-1/5-CYANO-1,3-DIHYDROXYMETHYLBENZENE
- 146335-44-6/3-Cyclohexene-1-carboxylicacid,4-amino-6,6-dimethyl-2-oxo-,methylester
- 146337-41-9/1-BOC-2-AZEPANECARBALDEHYDE
- 146337-49-7/1-BOC-2-TRIMETHYLSILANYL-INDOLE
- 146340-00-3/[hydroxy-[(3E,7E,11E,15E,19E,23E,27E,31E)-4,8,12,16,20,24,28,32,36-nonamethylheptatriaconta-3,7,11,15,19,23,27,31,35-nonaenoxy]phosphoryl]oxyphosphonic acid
- 146340-15-0/Alcohols, C12-14-secondary, .beta.-(2-hydroxyethoxy), ethoxylated
- 146340-20-7/ACTIVATED PROTEIN C (390-404) (HUMAN)
- 146346-82-9/FMOC-THR(TBDMS)-OH
- 146350-85-8/1H-Benzimidazole,2-butyl-5-fluoro-(9CI)
- 146350-88-1/1H-Benzimidazole,2-(3-pentenyl)-(9CI)
- 146350-89-2/1H-Benzimidazole,2-(1-butenyl)-(9CI)
- 146350-90-5/1-Butanone,1-(1H-benzimidazol-2-yl)-(9CI)
- 146350-91-6/1H-Benzimidazole,2-(cyclopentylmethyl)-(9CI)
- 146350-93-8/1H-Benzimidazole,2-(2-cyclopenten-1-ylmethyl)-(9CI)
- 142160-11-0/Phosphetane, 1,1-bis(1,1-dimethylethyl)-1-fluoro-1,1-dihydro-